Linden Thomas Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $892K | Buy |
11,400
+186
| +2% | +$14.5K | 0.1% | 307 |
|
|
2025
Q1 | $813K | Buy |
11,214
+849
| +8% | +$61.5K | 0.11% | 309 |
|
|
2024
Q4 | $767K | Buy |
10,365
+221
| +2% | +$16.4K | 0.1% | 327 |
|
|
2024
Q3 | $669K | Buy |
10,144
+558
| +6% | +$36.8K | 0.09% | 336 |
|
|
2024
Q2 | $885K | Buy |
9,586
+1,873
| +24% | +$173K | 0.14% | 284 |
|
|
2024
Q1 | $737K | Buy |
7,713
+698
| +10% | +$66.7K | 0.12% | 306 |
|
|
2023
Q4 | $535K | Buy |
7,015
+527
| +8% | +$40.2K | 0.1% | 327 |
|
|
2023
Q3 | $449K | Sell |
6,488
-7,960
| -55% | -$551K | 0.1% | 337 |
|
|
2023
Q2 | $1.36M | Buy |
14,448
+687
| +5% | +$64.8K | 0.3% | 128 |
|
|
2023
Q1 | $1.14M | Buy |
13,761
+475
| +4% | +$39.3K | 0.28% | 149 |
|
|
2022
Q4 | $991K | Buy |
+13,286
| New | +$991K | 0.28% | 157 |
|